Live Breaking News & Updates on நோவர்த்திச் மருந்துகள் கனடா

Stay updated with breaking news from நோவர்த்திச் மருந்துகள் கனடா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ilaris® receives Health Canada approval as first of its kind treatment for rare, inflammatory disorder, adult-onset Still's disease

Share this article
Share this article
The approval of Ilaris (canakinumab) in the treatment of adult-onset Still s disease (AOSD) brings hope for Canadians living with this rare, debilitating, and sometimes life-threatening inflammatory disorder.
Ilaris, an interleukin-1 beta inhibitor, provides a new mode of treatment for this disease
which previously had limited options.
1,2
DORVAL, QC, April 29, 2021 /CNW Telbec/ - Novartis Pharmaceuticals Canada Inc. is pleased to announce that Health Canada has approved Ilaris
®
(canakinumab) for the treatment of active Still s disease, including adult-onset Still s disease (AOSD)
1. AOSD is a rare form of inflammatory arthritis that can be a complex disease with variable presentation and potentially life-threatening complications ....

Julie Schneiderman , Derek Haaland , Andrea Marazzi , Novartis Pharmaceuticals Canada , Novartis Pharmaceuticals Canada Inc , Novartis Corporate Communications , Health Canada , Pharmaceuticals Canada , Systemic Juvenile Idiopathic Arthritis , Country Head , Novartis Pharmaceuticals , Periodic Fever Syndromes , Cryopyric Associated Periodic Syndrome , Pharmaceuticals Canada Inc , Clinical Risk Management , Adult Onset Still , Onset Still , Autoimmunity Reviews , Novartis Media Relations , ஜூலி ஸ்ச்சினெதெர்மன் , ஆண்ட்ரியா மராஸி , நோவர்த்திச் மருந்துகள் கனடா , நோவர்த்திச் மருந்துகள் கனடா இன்க் , நோவர்த்திச் பெருநிறுவன தகவல்தொடர்புகள் , ஆரோக்கியம் கனடா , மருந்துகள் கனடா ,

Novartis in Canada named a Top 50 Best Workplace™ in the country

Novartis in Canada named a Top 50 Best Workplace™ in the country
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Novartis Innovative Medicines Division Pharmaceuticals , Novartis Pharmaceuticals Canada Inc , Novartis Pharmaceuticals Canada , Great Place , Novartis Innovative Medicines Division , Christian Macher , Country President , Pharmaceuticals Canada Inc , Sandoz Canada , Pharmaceuticals Canada , Novartis Innovative Medicines Division , நோவர்த்திச் மருந்துகள் கனடா இன்க் , நோவர்த்திச் மருந்துகள் கனடா , நன்று இடம் , நாடு ப்ரெஸிடெஂட் , மருந்துகள் கனடா இன்க் , சாண்டோஸ் கனடா , மருந்துகள் கனடா ,

Pharma Companies Seeking to Improve Health Outcomes With Innovative Products

Pharma Companies Seeking to Improve Health Outcomes With Innovative Products
- FN Media Group Presents Microsmallcap.com Market Commentary
News provided by
Share this article
Share this article
NEW YORK, April 8, 2021 /PRNewswire/ Conditions such as HIV, asthma, hepatitis, and severe migraines affect the quality of life of those living with these conditions. These conditions require patients to take preventive or control medication to avoid adverse developments due to the conditions. Pharmaceutical companies like
Valeo Pharma Inc. (CSE:VPH) (OTCQB:VPHIF),
Pfizer (NYSE:PFE),
AbbVie Inc. (NYSE:ABBV), and
Gilead Sciences (NASDAQ:GILD) have taken note of the challenges of managing these conditions and the potential of exacerbations and worse outcomes for people with poorly managed conditions. They have developed drugs and advanced care therapies that improve the management of these conditions. These developments in the pharmaceutical industry ....

Enerzair Breezhaler , Albert Bourla , Michael Berg , Valeo Pharma , Atectura Breezhaler , Frederic Fasano , Andrea Marazzi , Head Country Pharma Organization , Gilead Sciences , Novartis Pharmaceuticals Canada Inc , Development Of More Effective Treatments , Fn Media Group , Valeo Pharma Inc , Research Key , Exchange Commission , Securities Exchange , Abbvie Inc , Abbott Laboratories , Novartis Pharmaceuticals Canada , More Effective , Chief Executive Albert Bourla , Democratic Republic , New Drug Application , Michael Gold , Danielo Day , Securities Act ,

Valeo Pharma Reports its First Quarter 2021 Results and Highlights

Valeo Pharma Reports its First Quarter 2021 Results and Highlights
newswire.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswire.ca Daily Mail and Mail on Sunday newspapers.

Steve Saviuk , Frederic Dumais , Valeo Pharma , Luc Mainville , Frederic Fasano , Quebec Institut , Quebec Valeo Pharma , Montreal Heart Institute , Head Office , Novartis Pharmaceuticals Canada Inc , Valeo Pharma Inc , Montreal Institute Of Cardiology , Health Canada , Chief Operating , Novartis Canada , Montreal Institute , Senior Vice President , Chief Financial Officer , Sodium Ethacrynate , Product Highlights , Health Minister , Depository Trust Company , Ethacrynate Sodium , Supply Agreement , Novartis Pharmaceuticals Canada , Hesperidin Coronavirus ,

Alberta provides treatment for genetic disorder

Alberta provides treatment for genetic disorder
Poll
Yes
By Dale Woodard on January 30, 2021.
Alberta families of children with a rare genetic disorder received some good news on the treatment front Wednesday when it was announced children suffering from spinal muscular atrophy may now be eligible to receive funding for gene replacement therapy treatment.
Alberta’s government is working with Novartis Pharmaceuticals Canada Inc. to provide interim patient access to Zolgensma.
Spinal muscular atrophyÂ is a rare and progressive genetic disorder that causes muscle wasting. Alberta children with SMA and who may become ineligible for the treatment while waiting for the final approval processes to be completed will be considered for funding on a case-by-case basis. ....

Susi Vander Wyk , Jeank Mah , Division Of Pediatric Neurology , Pan Canadian Pharmaceutical Alliance , Novartis Pharmaceuticals Canada Inc , Canadian Agency For Drugs , Health Tyler Shandro , Health Canada , Technologies In Health , Dale Woodard , Novartis Pharmaceuticals Canada , Alberta Minister , Canadian Agency , Alberta Government , Pediatric Neurology , Alberta Children , Vander Wyk , சூசி வாண்டர் விக் , பிரிவு ஆஃப் குழந்தை நரம்பியல் , பான் கனடியன் மருந்து கூட்டணி , நோவர்த்திச் மருந்துகள் கனடா இன்க் , ஆரோக்கியம் கனடா , தொழில்நுட்பங்கள் இல் ஆரோக்கியம் , டேல் மரம் , நோவர்த்திச் மருந்துகள் கனடா , ஆல்பர்ட்டா அமைச்சர் ,